Home » Genentech Example Raises Flags for Genzyme
Genentech Example Raises Flags for Genzyme
A cost-cutting push unveiled Friday by the Swiss drug maker Roche Holding AG, which last year paid $46.8 billion for the US biotechnology giant Genentech Inc., has raised fresh questions about the fate of Genzyme Corp., a Cambridge biotech.
boston
boston
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May